Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117683734 | 11768373 | 4 | F | 201204 | 20160816 | 20151123 | 20160819 | EXP | US-PFIZER INC-2015395547 | PFIZER | 57.00 | YR | F | Y | 74.00000 | KG | 20160819 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117683734 | 11768373 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, 1X/DAY | U | 20702 | 80 | MG | FILM-COATED TABLET | QD | |||||
| 117683734 | 11768373 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, 1X/DAY (OBLONG TABLET ONCE AT NIGHT) | U | 20702 | 80 | MG | FILM-COATED TABLET | QD | |||||
| 117683734 | 11768373 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 117683734 | 11768373 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 117683734 | 11768373 | 5 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 117683734 | 11768373 | 6 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 117683734 | 11768373 | 7 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, 1X/DAY | U | 20702 | 80 | MG | FILM-COATED TABLET | QD | |||||
| 117683734 | 11768373 | 8 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 117683734 | 11768373 | 9 | C | ZESTRIL | LISINOPRIL | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | |||||||||
| 117683734 | 11768373 | 10 | C | COREG | CARVEDILOL | 1 | 3.125 MG, 2X/DAY | 0 | 3.125 | MG | BID | ||||||||
| 117683734 | 11768373 | 11 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117683734 | 11768373 | 1 | Low density lipoprotein increased |
| 117683734 | 11768373 | 2 | Cardiovascular event prophylaxis |
| 117683734 | 11768373 | 3 | Blood cholesterol increased |
| 117683734 | 11768373 | 4 | Blood triglycerides increased |
| 117683734 | 11768373 | 5 | Lipids increased |
| 117683734 | 11768373 | 6 | Myocardial infarction |
| 117683734 | 11768373 | 7 | Blood cholesterol increased |
| 117683734 | 11768373 | 8 | Lipids increased |
| 117683734 | 11768373 | 9 | Cardiac disorder |
| 117683734 | 11768373 | 10 | Cardiac disorder |
| 117683734 | 11768373 | 11 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117683734 | 11768373 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117683734 | 11768373 | Fatigue | |
| 117683734 | 11768373 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117683734 | 11768373 | 1 | 20090529 | 20120109 | 0 | |
| 117683734 | 11768373 | 2 | 2010 | 0 | ||
| 117683734 | 11768373 | 7 | 20120119 | 0 | ||
| 117683734 | 11768373 | 9 | 2010 | 0 | ||
| 117683734 | 11768373 | 10 | 2010 | 0 | ||
| 117683734 | 11768373 | 11 | 2010 | 0 |